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Abstract 
Background: Dynamic arterial elastance (Eadyn), defined as the ratio between pulse pressure variations and stroke 
volume variations, has been proposed to assess functional arterial load. We evaluated the evolution of Eadyn during 
volume expansion and the effects of neosynephrine infusion in hypotensive and preload‑responsive patients.
Methods: In this prospective bicentre study, we included 56 mechanically ventilated patients in the operating room. 
Each patient had volume expansion and neosynephrine infusion. Stroke volume and stroke volume variations were 
obtained using esophageal Doppler, and pulse pressure variations were measured through the arterial line. Pressure 
response to volume expansion was defined as an increase in mean arterial pressure (MAP) ≥ 10%.
Results: Twenty‑one patients were pressure responders to volume expansion. Volume expansion induced a decrease 
in Eadyn (from 0.69 [0.58–0.85] to 0.59 [0.42–0.77]) related to a decrease in pulse pressure variations more pronounced 
than the decrease in stroke volume variations. Baseline and changes in Eadyn after volume expansion were related to 
age, history of arterial hypertension, net arterial compliance and effective arterial elastance. Eadyn value before vol‑
ume expansion > 0.65 predicted a MAP increase ≥ 10% with a sensitivity of 76% (95% CI 53–92%) and a specificity of 
60% (95% CI 42–76%). Neosynephrine infusion induced a decrease in Eadyn (from 0.67 [0.48–0.80] to 0.54 [0.37–0.68]) 
related to a decrease in pulse pressure variations more pronounced than the decrease in stroke volume variations. 
Baseline and changes in Eadyn after neosynephrine infusion were only related to heart rate.
Conclusion: Eadyn is a potential sensitive marker of arterial tone changes following vasopressor infusion.
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Introduction
Many recent studies have underlined the point that 
perioperative hypotension could lead to worse patient 
outcome mainly because of myocardial injury, cerebro-
vascular disease and acute kidney injury [1–3]. Therefore, 
understanding the origins of perioperative hypotension 
and its prevention is essential to proposing a judicious 
treatment modality. Basically, the two principal strate-
gies to correct perioperative hypotension are vasopres-
sor infusion and/or volume expansion. During the last 
decade, many studies tested different indices and their 
abilities to predict an increase in stroke volume follow-
ing fluid administration and/or vasopressor infusion 
[4–6]. Additionally, the prediction of an increase in arte-
rial pressure following volume expansion has been widely 
studied.
Several years ago, Pinsky et  al. proposed a pragmatic, 
easy-to-use and physiologically robust approach of 
dynamic arterial elastance [7]. Schematically, arterial 
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elastance (Ea) is defined as the ratio of changes in pres-
sure to changes in volume. Dynamic arterial elastance 
(Eadyn) could therefore be assessed using the ratio 
between respiratory-induced changes in arterial pulse 
pressure and respiratory-induced changes in stroke 
volume during a single respiratory cycle. Several stud-
ies investigated the clinical utility of Eadyn. The most 
robust data concern the evolution of Eadyn as an indica-
tor of decrease in arterial pressure following a reduction 
in norepinephrine dosage in septic shock patients [8]. A 
randomized control trial demonstrated that a therapeu-
tic protocol based on Eadyn may be an efficient guide 
to decrease norepinephrine infusion in patients follow-
ing cardiac surgery [9]. Other studies investigated the 
ability of Eadyn to predict an increase in arterial pres-
sure following volume expansion with discordant results 
[10–15]. Results of studies including ICU septic patients 
with acute circulatory failure and receiving vasopres-
sors are very promising [13, 16, 17]. On the another 
hand, studies including operating room patients with-
out vasopressor support and suffering from non-septic 
hypovolemia showed conflicting results [11, 12, 15, 18]. 
We can hypothesize that volume expansion induces dif-
ferent effects on arterial compliance in patients receiving 
vasopressors or not. Hence, it affects Eadyn in a differ-
ent way. The very rare studies carried out in the operat-
ing theater included very specific patients (liver failure or 
laparoscopy). Before proposing the use of Eadyn to guide 
low blood pressure treatment in the operating room, it 
would be necessary to perform a prospective study on 
patients, under general anesthesia and are not receiving 
vasopressors.
The objectives of this bicentre study were to (i) describe 
Eadyn variations induced by volume expansion and vaso-
pressor infusion, (ii) describe the relationship between 
baseline Eadyn and the increase in arterial pressure 
induced by volume expansion and vasopressor infusion 
and (iii) test the ability of baseline Eadyn to predict an 
increase in arterial pressure following volume expansion 
in the operating room.
Materials and methods
Patients
This prospective, bicentre study was approved by the 
Institutional Review Board (Comité de Protection des 
Personnes Sud-Ouest et Outre Mer III, Bordeaux, France 
N°DC2016/125) and was registered at French National 
Commission for Data Protection and Liberties (CNIL 
N°1980317).
Fifty-six non-consecutive patients were included after 
oral informed consent. (Written informed consent was 
waived by the Institutional Review Board.) Inclusion cri-
teria were patients scheduled for neurosurgery or elective 
abdominal surgery, older than 18  years, equipped with 
radial arterial catheter and esophageal Doppler (CardioQ 
ODM+, Deltex Medical, Chichester, UK) for cardiac out-
put monitoring. Non-inclusion criteria were preoperative 
lung disease, intracranial hypertension, left ventricular 
ejection fraction below 50%, arrhythmia, suspected right 
ventricular dysfunction, extreme body weight (BMI > 40 
or < 15 kg/m2).
Perioperative management
Standard monitoring included noninvasive blood pres-
sure, heart rate, peripheral oxygen saturation and con-
tinuous electrocardiography. After preoxygenation, 
anesthesia was induced using propofol and remifentanil 
or sufentanil. Propofol or sevoflurane and remifentanil 
or sufentanil were used for maintenance of anesthesia. 
Following tracheal intubation, patient’s lungs were ven-
tilated with a mixture of air/oxygen using volume con-
trol mode. Tidal volume was set between 6 and 8 ml/kg 
of ideal body weight, and positive end-expiratory pres-
sure was set between 6 and 10  cmH2O (Primus, Dräger, 
Lübeck, Germany, or Avance, General Electric Health-
care, Helsinki, Finland). Peripheral oxygen saturation 
was maintained above 96%, and the respiratory rate was 
adjusted to maintain end-tidal carbon dioxide concentra-
tion between 30 and 35 mmHg. The inspiratory-to-expir-
atory ratio was set to 1/2.
Hemodynamic monitoring
All patients were equipped with a radial arterial catheter 
inserted just after the induction of anesthesia (Vygon, 
Ecouen, France). The catheter was connected to a bedside 
monitor (Spacelabs Healthcare Company Headquarters, 
Issaquah, WA, USA, or IntelliVue MP70, Philips Health-
care, Andover, MA, USA) for mean arterial pressure 
(MAP) and pulse pressure variation (PPV) monitoring. 
After tracheal intubation, the probe was inserted into the 
esophagus via the nasal route and the good quality of the 
signal was confirmed as previously described.
PPV was derived from the bedside monitor by manual 
calculation of the difference between systolic and dias-
tolic blood pressure. The maximal (Pulse Pressure max) 
and minimal (Pulse Pressure min) differences were deter-
mined during three consecutive respiratory cycles. The 
mean values of the three measurements were used to 
calculate arterial pulse pressure variability: PPV = (Pulse 
Pressure max  −  Pulse Pressure min)/[(Pulse Pres-
sure max + Pulse Pressure min)/2] × 100, as previously 
described [19]. PPV was measured directly on the moni-
tor using a screenshot.
Stroke volume, cardiac output, stroke volume varia-
tion (SVV), corrected flow time and peak velocity of aor-
tic blood flow were assessed using esophageal Doppler 
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(CardioQ ODM+, Deltex Medical, Gamida, Eaubonne 
France). SVV was calculated automatically as follows: 
(Stroke Volume max − Stroke Volume min)/[(Stroke Vol-
ume max + Stroke Volume min)/2] over one respiratory 
cycle. The SVV value was averaged over five respiratory 
cycles [20]. SVV value was recorded immediately after 
the measurement of PPV in order to record two values 
that covered the same time period.
Eadyn was calculated as the ratio between PPV and 
SVV. Net arterial compliance (C) was calculated as 
the ratio between stroke volume and pulse pressure 
[21]. Arterial resistance (R) was calculated as the ratio 
between mean arterial pressure and cardiac output. Arte-
rial elastance was calculated using these two formulas: 
 EaSAP = (systolic arterial pressure  ×  0.9)/stroke volume 
and  EaMAP = mean arterial pressure/stroke volume [22, 
23].
Study design
Measurements were performed in the operating room, 
between the end of induction of anesthesia and the end 
of surgery. Volume expansions and neosynephrine infu-
sions were performed according to the routine care of the 
patients. Each patient received volume expansion before 
neosynephrine infusion. If several volume expansions or 
neosynephrine infusions were done in one patient, only 
the first volume expansion or the first neosynephrine 
infusion was recorded.
Volume expansion was performed if MAP ≤ 65 mmHg 
and SVV > 10%, and neosynephrine was infused if 
MAP ≤ 65 mmHg regardless of the SVV value, on the dis-
cretion of the physician in charge.
Volume expansion was done with 250  ml 0.9% saline 
over 10  min. One set of measurements was performed 
immediately before volume expansion, and the second set 
was done 2–3 min after the end of fluid administration.
Vasopressor infusion consisted of a fixed dose of 50 
mcg of neosynephrine. One set of measurements was 
performed immediately before vasopressor infusion, and 
the second set was performed 2 to 3 min after the infu-
sion when MAP was stabilized (MAP variation below 5% 
during 1 min).
Patients with hemodynamic instability requiring a 
decrease (or an increase) in anesthesia drug dosage, fluid 
infusion or administration of vasopressors other than in 
the protocol were excluded. Another exclusion criterion 
was any change in ventilatory setting by the physician in 
charge of the patient.
Statistical analysis
Data are expressed as median [percentile, 25–75] or 
mean ± SD where appropriate. Normality of the distribu-
tion was tested using D’Agostino–Pearson test. Pressure 
response to volume expansion was defined as an increase 
in MAP ≥ 10% [13, 14]. The effects of neosynephrine and 
volume expansion on hemodynamic parameters were 
analyzed using Wilcoxon rank sum test. Mann–Whitney 
test was used to compare hemodynamic variables before 
fluid challenge or neosynephrine infusion in pressure 
non-responder and responder patients. The relationship 
between Eadyn and changes in MAP induced by volume 
expansion was tested using Spearman rank test.
The receiver-operating characteristic (ROC) curves 
were generated for Eadyn and MAP to test their abilities 
to predict pressure response to volume expansion. Area 
under the receiver-operating characteristic curves were 
compared using De Long test [24]. The best threshold 
values were identified using the Youden Index (speci-
ficity + sensitivity  −  1). The gray zone was determined 
as follows: The low cutoff value was defined to exclude 
positive fluid challenge in 90% of patients, whereas the 
high cutoff value was defined to predict positive fluid 
challenge in 90% of cases [25]. A diagnostic test is con-
sidered to have good accuracy when its area under the 
ROC curve is ≥ 0.75 [26]. Fifty-six patients were needed 
to demonstrate the ability of Eadyn to predict pressure 
responsiveness with good accuracy, i.e., area under the 
ROC curve > 0.75 (ratio of pressure responders = 1/3, null 
hypothesis = 0.50, type I error of 5% and type II error of 
10%).
Random effects models were estimated in order to 
study the effect of several covariates on the temporal evo-
lution of Eadyn, SVV and PPV during fluid challenge and 
neosynephrine infusion.
For each hemodynamic maneuver (i.e., fluid challenge 
and neosynephrine infusion), two different models were 
estimated for Eadyn, PPV and SVV. The first model 
included covariates related to arterial load and the sec-
ond cardiac covariates. Each model was a fully adjusted 
model including all covariates of the study. Only baseline 
values (before hemodynamic maneuver) were included. 
To study the effect of covariates on temporal evolution of 
Eadyn, PPV and SVV, random effects models were esti-
mated with subjects being considered as the random fac-
tors. For each random effects model, because only two 
repeated measurements were performed, we considered 
time function as linear. Hence, we estimated the fixed 
intercept, fixed effects, random intercept and time inter-
action between time and each covariate. The contribution 
of each covariate on temporal evolution was tested by a 
Wald test on the time–covariate interaction term [27].
Statistical analysis was performed using Medcalc (soft-
ware 11.6; Mariakerke, Belgium) and R Development 
Core Team ([2008]. R: A language and environment for 
statistical computing; R Foundation for Statistical Com-
puting, Vienna, Austria. ISBN 3-900051-07-0, URL).
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Results
Patient characteristics
Fifty-six patients were included (Fig.  1). Patient charac-
teristics are shown in Table  1. Hemodynamic variables 
are shown in Table 2. The distribution of Eadyn was not 
normal. Each patient received volume expansion before 
neosynephrine infusion.
Effects of volume expansion
Volume expansion induced a significant increase in arte-
rial pressure (systolic, diastolic, mean and pulse pres-
sure), stroke volume (16% [10–25%]), cardiac output (14% 
[10–18%]) and net arterial compliance associated with a 
significant decrease in heart rate, PPV, SVV, Eadyn, Ea 
and R (Table 2 and Fig. 2a). Forty-five patients presented 
an increase in stroke volume ≥ 10%. Volume expansion 
induced a significantly larger decrease in PPV than in 
SVV: (− 27% (− 48 to − 13%) versus − 15% (− 29 to 0%), 
respectively), p = 0.0002. Baseline and changes in Eadyn 
after volume expansion were related to age, arterial 
hypertension, compliance and effective arterial elastance 
(Tables  3, 4). After volume expansion, Eadyn decreased 
in 38 patients (68%), remained unchanged in 2 patients 
(4%) and increased in 16 patients (29%). Twenty-one 
patients were pressure responders to volume expan-
sion. Prior to volume expansion, Eadyn was higher and 
MAP lower in responder than in non-responder patients 
(Table  5). Volume expansion induced different pressure 
effects in responders and non-responder patient. Ea, C 
and R were similar after volume expansion in pressure 
responders, whereas Ea and R decreased and C increased 
in non-responder patients (Table 5).
Effects of neosynephrine infusion
Neosynephrine infusion induced a decrease in heart rate, 
stroke volume, PPV, SVV, Eadyn and C and an increase 
in arterial pressure (systolic, diastolic, mean and pulse 
pressure), Ea and R (Fig.  2b) and an increase in MAP 
(Table  2). Neosynephrine infusion induced a signifi-





Unanalyzable Doppler values / 
insufficient signal quality 
(n=5) 
Patients with hemodynamic 
instability requiring a decrease in 
anesthesia drug dosage or 
administration of vasopressors other 
than in the protocol 
(n=3)
Change in ventilatory setting 
(n=1)
Fig. 1 Flowchart of patients screened and included in the study
Table 1 Main characteristics of patients (n = 56)
Values are mean ± SD, or median [percentile 25–75] or number (n)
FIO2 inspired oxygen fraction, ACE angiotensin-converting enzyme, ARB 







Age (years) 57 ± 13 54 ± 14 60 ± 11
Sex, M/F (n) 21/35 16/27 5/8
Height (cm) 168 ± 9 169 ± 9 169 ± 11
Weight (kg) 72 ± 15 73 ± 15 67 ± 16
Ideal body weight (kg) 62 ± 10 62 ± 9 63 ± 11
Tidal volume (ml) 455 ± 66 441 ± 55 500 ± 79
Tidal volume (ml/kg of ideal body 
weight)
7.4 ± 0.8 7.2 ± 0.7 8.0 ± 0.7
Respiratory rate (cycles/min) 13 ± 1 13 ± 1 12 ± 1
Positive end‑expiratory pressure 
 (cmH2O)
5 [5–6] 5 [5–6] 6 [5–8]
FIO2 (%) 45 [40–50] 45 [40–50] 45 [40–45]
Driving pressure  (cmH2O) 11 ± 3 11 ± 3 8 ± 2
ASA status I/II/III 7/16/33 5/9/29 2/7/4
Surgery (n)
 Neurosurgery 43 43 0
 Abdominal surgery 13 0 13
Comorbidities
 Arterial hypertension 17 16 1
 Smoking 5 4 1
 Diabetes 4 4 0
 Stroke 2 2 0
Medications
 ACE inhibitors 9 7 2
 Statins 5 5 0
 Calcium blockers 5 4 1
 ARB 5 4 1
 Antidiabetic drug 3 3 0
 Beta‑blockers 2 2 0
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to −  18%)) versus −  14% (−  28 to 0%), respectively), 
p < 0.0001. Baseline and changes in Eadyn after neosyn-
ephrine infusion were only related to baseline heart rate 
(Tables 3, 4).
Relationship between Eadyn and MAP
We observed a weak correlation between baseline Eadyn 
and the increase in MAP induced by volume expansion 
(r2 = 0.11; p = 0.01). However, there was neither any 
correlation between baseline Eadyn and baseline MAP 
values (p = 0.1) nor between changes in Eadyn and the 
increase in MAP associated with volume expansion.
Concerning neosynephrine infusion, there was no 
correlation between baseline Eadyn and baseline MAP 
values (p = 0.3), between baseline Eadyn and neosyn-
ephrine-induced increase in MAP (p = 0.76) and between 
neosynephrine-induced changes in Eadyn and neosyn-
ephrine-induced changes in MAP (p = 0.88).
Prediction of pressure response to volume expansion
Eadyn values before volume expansion in pressure 
responders and non-responders are shown in Fig.  3. 
Baseline Eadyn value > 0.65 before volume expansion 
predicted an increase ≥ 10% in MAP with a sensitivity of 
76% (95% CI 53–92%) and a specificity of 60% (95% CI 
42–76%) (Fig.  4). The baseline MAP value ≤ 57  mmHg 
predicted an increase ≥ 10% in MAP with a sensitivity of 
71% (95% CI 48–89%) and a specificity of 74% (95% CI 
57–88%). Gray zones ranged from 0.59 to 0.98 for Eadyn 
(included 52% of patients) and from 52 to 64 mmHg for 
MAP (including 77% of patients). The area under the 
ROC curve generated for baseline Eadyn (0.71, 95% CI 
0.57 to 0.84) was similar to the one generated for base-
line MAP (0.72, 95% CI 0.57–0.87), p = 0.89 (Fig.  4 and 
Table 6). Baseline Eadyn value < 0.52 was associated with 
a negative predictive value of 100% (positive predictive 
value of 48%).
Eleven patients presented an increase in stroke vol-
ume less than 10% (8% [5–9%]). When these eleven vol-
ume non-responder patients were excluded, the AUC 
generated for Eadyn and MAP was not different from 
the AUC generated with all patients included (0.75, 95% 
CI 0.60 to 0.87 versus 0.71, 95% CI 0.57 to 0.84 (p > 0.05) 
and 0.75, 95% CI 0.60 to 0.86 versus 0.72, 95% CI 0.57 to 
0.87, respectively (p > 0.05)). The best threshold values for 
Eadyn and MAP were also similar.
Discussion
This bicentre study suggests that in hypotensive and 
preload-responsive patients (i) both volume expansion 
and vasopressor infusion induced a decrease in Eadyn, (ii) 
very poor or no relationship was found between baseline 
Eadyn and changes in MAP induced by volume expan-
sion or vasopressor infusion and (iii) baseline Eadyn was 
moderately able to predict the increase in MAP (but not 
Table 2 Hemodynamic variables before and after volume expansion/neosynephrine infusion
Values are median [percentile, 25–75]
C net arterial compliance, DAP diastolic arterial pressure, Ea arterial elastance, Eadyn dynamic arterial elastance, FTc corrected aortic flow time, MAP mean arterial 
pressure, VE volume expansion, NEO neosynephrine, PP arterial pulse pressure, PPV pulse pressure variations, PV peak velocity of aortic blood flow, R arterial 
resistance, SAP systolic arterial pressure, SVV stroke volume variations, P1 p value of the difference obtained before and after volume expansion, P2 p value of the 
difference obtained before and after neosynephrine infusion
Before VE After VE P1 Before NEO After NEO P2
Heart rate (bpm) 64 [58–74] 60 [55–71] < 0.0001 60 [56–71] 57 [52–65] < 0.0001
SAP (mmHg) 80 [75–86] 83 [78–89] 0.006 80 [77–87] 102 [93–115] < 0.0001
MAP (mmHg) 59 [53–64] 63 [59–66] < 0.0001 60 [55–64] 75 [69–85] 0.0001
DAP (mmHg) 47 [43–50] 48 [43–52] 0.04 48 [43–51] 59 [54–65] < 0.0001
PP (mmHg) 32 [28–38] 35 [30–40] 0.004 34 [29–39] 44 [36–52] < 0.0001
Stroke volume (ml) 64 [54–81] 76 [63–97] < 0.0001 81 [66–96] 64 [55–82] < 0.0001
Cardiac output (l/min) 4.4 [3.5–5.3] 4.9 [3.7–6.2] < 0.0001 4.9 [4.0–6.1] 3.8 [2.9–5.0] < 0.0001
PPV (%) 12 [8–14] 8 [6–10] < 0.0001 9 [6–11] 6 [4–9] < 0.0001
SVV (%) 16 [12–22] 14 [11–17] < 0.0001 14 [10–16] 11 [8–15] 0.0005
Eadyn 0.69 [0.58–0.85] 0.59 [0.42–0.77] 0.0002 0.67 [0.48–0.80] 0.54 [0.37–0.68] < 0.0001
Ea (mmHg/ml)/SAP 1.06 [0.89–1.34] 0.91 [0.77–1.16] < 0.0001 0.90 [0.77–1.12] 1.42 [1.08–1.88] < 0.0001
Ea (mmHg/ml)/MAP 0.92 [0.69–1.11] 0.80 [0.63–0.99] < 0.0001 0.72 [0.60–0.93] 1.09 [0.89–1.53] < 0.0001
C (ml/mmHg) 2.11 [1.67–2.46] 2.33 [1.70–2.81] 0.001 2.37 [1.96–2.81] 1.57 [1.14–1.94] < 0.0001
R (mmHg/s/ml) 13.3 [10.8–16.9] 12.8 [9.6–17.3] 0.01 12.1 [9.4–14.9] 20.5 [13.7–28.1] < 0.0001
FTc (ms) 305 [269–333] 323 [291–354] < 0.0001 326 [267–351] 303 [280–333] < 0.0001
PV (cm/s) 69 [58–89] 72 [62–91] 0.0004 75 [62–94] 64 [54–77] < 0.0001
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significantly different from MAP baseline values), follow-
ing volume expansion.
Ea and Eadyn
The arterial load describes all the extracardiac factors 
opposing left ventricular ejection [28]. In clinical prac-
tice, arterial load is often related to systemic vascular 
resistance. However, this approach does not take into 
account the cyclic nature of the blood pressure and 
flow imposed by cardiac contractions. A more accurate 
and precise insight of arterial load is the evaluation of 
aortic input impedance, but it is not feasible at the bed-
side. Sunagawa proposed that a single variable called 
effective arterial elastance or Ea could integrate all the 
components of aortic impedance [29]. A dynamic and 
functional assessment of arterial load called dynamic 
arterial elastance has been proposed a few years ago. It 
represents the dynamic interaction between changes in 
arterial pressure and stroke volume during a respiratory 
cycle. Several studies have evaluated this new approach, 
in particular the ability of Eadyn to predict an increase 
in arterial pressure following volume expansion. Most 
of these studies on patients treated with vasopressors 
revealed discordant results [8–13]. The originality of our 
study is to include mechanically ventilated patients in 
the operating room who are not receiving vasopressors 
which may alter arterial load.
Effects of volume expansion
The present study shows that in pressure responder 
patients, volume expansion increases stroke volume and 
has no effect on arterial load, leading to an increase in 
arterial pressure. On the other hand, in pressure non-
responder patients, volume expansion increases stroke 
volume associated with vasodilation (shear stress) 
attested by an increase in arterial compliance and a 
decrease in resistance. Volume expansion induced a 
decrease in Eadyn mainly due to a larger decrease in 
PPV than in SVV. Changes in PPV were related to arte-
rial load covariates, whereas changes in SVV were not. 
This may be explained by the fact that PPV was measured 
peripherally in a radial artery and was sensitive to arterial 
properties, whereas SVV was measured at the level of the 
descending aorta. We found that both Eadyn and PPV 
were related to arterial hypertension and age. This find-
ing is consistent with a previous study [18] and is prob-
ably related to arterial stiffness.
Eadyn and vasopressors
Using Eadyn as a physiological marker of arterial tone 
during vasopressor utilization seems plausible. Vasopres-
sor infusion induces a systematic effect on arterial load 
which could be assessed by Eadyn. Some studies evalu-
ated the evolution of Eadyn as an indicator of decrease in 
arterial pressure following a reduction in norepinephrine 
dosage in septic shock patients [8]. A randomized control 
trial demonstrated that a therapeutic protocol based on 
Eadyn may be an efficient guide to decrease norepineph-
rine infusion in patients following cardiac surgery [9]. 
In the present study, we observed a significant decrease 
in Eadyn following neosynephrine infusion in 89% of 
patients. Neosynephrine infusion induces vasoconstric-
tion (increase in resistance and decrease in compliance) 
and a decrease in both stroke volume and cardiac output. 
We observed that both contractility and preload param-
eters were impacted. The present study was not designed 
to elucidate this issue. We found that arterial load and 
cardiac covariates have very few or no effect on the time 
course of Eadyn, PPV and SVV. This could be explained 
by the predominant effect of neosynephrine on the rest 









































Fig. 2 a Box plot (median values, inter‑quartile range) and individual 
values of dynamic arterial elastance (Eadyn) before and after volume 
expansion. b Box plot (median values, inter‑quartile range) and 
individual values of dynamic arterial elastance (Eadyn) before and 
after neosynephrine (NEO) infusion
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Clinical use of Eadyn
Based on our experience, an isolated measurement 
of Eadyn could not inform the clinician of a possible 
increase in blood pressure after volume expansion. This 
remains true, even if we focus only on patients exhib-
iting an increase in stroke volume ≥ 10% after volume 
expansion (n = 45). Our results are in contradiction 
with some previous studies [11, 12, 25]. Some of the 
main factors explaining these differences were the fact 
that our patients were neither septic nor recipients of 
vasopressor treatment. This is of major importance 
because vasopressor infusion can alter arterial load. 
For example, arterial compliance does not change fol-
lowing volume expansion in patients treated with 
Table 5 Hemodynamic variables before and after volume expansion in responder and non-responder patients
Values are expressed as median [percentile, 25–75]
P1 difference between before and after VE in responders, P2 difference between before and after VE in non-responders, P3 difference between responders and non-
responders before volume expansion, responders MAP increase ≥ 10% after volume expansion, C net arterial compliance, DAP diastolic arterial pressure, Ea effective 
arterial elastance, Eadyn dynamic arterial elastance, FTc corrected aortic flow time, MAP mean arterial pressure, VE volume expansion, NEO neosynephrine, PP arterial 
pulse pressure, PPV pulse pressure variations, PV peak velocity of aortic blood flow, R arterial resistance, SAP systolic arterial pressure, SVV stroke volume variations
Responders (n = 21) Non-responders (n = 35)
Before VE After VE P1 Before VE After VE P2 P3
Heart rate (bpm) 62 [58–72] 60 [54–71] 0.0028 65 [57–74] 60 [56–71] < 0.0001 0.71
SAP (mmHg) 77 [66–80] 86 [79–93] 0.0001 82 [79–87] 80 [77–86] 0.49 0.0011
MAP (mmHg) 54 [51–59] 62 [60–66] 0.0001 65 [57–64] 69 [58–65] < 0.0001 0.006
DAP (mmHg) 43 [41–49] 50 [45–53] 0.0001 47 [43–51] 48 [41–52] 0.16 0.03
Stroke volume (ml) 60 [53–73] 72 [62–85] 0.0006 64 [55–92] 81 [67–97] < 0.0001 0.17
Cardiac output (l/min) 4.0 [3.3–4.6] 4.3 [3.5–5.7] 0.0005 4.6 [3.6–5.6] 5.4 [3.7–6.5] < 0.0001 0.10
PPV (%) 14 [11–19] 8 [7–11] 0.0001 10 [8–13] 8 [6–10] 0.0001 0.001
SVV (%) 16 [13–23] 14 [13–19] 0.0017 15 [12–21] 13 [10–16] 0.0006 0.46
Eadyn 0.75 [0.66–1.02] 0.57 [0.48–0.70] 0.0002 0.62 [0.48–0.82] 0.63 [0.39–0.82] 0.14 0.01
Ea (mmHg/ml)/SAP 1.06 [0.90–1.30] 1.06 [0.86–1.27] 0.34 1.06 [0.84–1.36] 0.88 [0.73–1.11] < 0.0001 0.96
Ea (mmHg/ml)/MAP 0.93 [0.69–1.1] 0.92 [0.70–0.97] 0.20 0.85 [0.67–1.12] 0.74 [0.60–1.00] < 0.0001 0.89
C (ml/mmHg) 2.15 [1.66–2.37] 2.02 [1.60–2.52] 0.30 2.09 [1.70–2.46] 2.38 [1.95–2.94] < 0.0001 0.91
R (mmHg/s/ml) 13.4 [10.5–18.0] 14.7 [9.6–20.1] 0.7 13.0 [10.9–16.5] 12.5 [9.4–17.0] 0.001 0.81
FTc (ms) 292 [266–306] 323 [298–334] 0.0002 317 [272–346] 331 [285–380] 0.0001 0.02

















Fig. 3 Box plot (median values, inter‑quartile range) and individual 
values of dynamic arterial elastance (Eadyn) before and after 
volume expansion in pressure responders (volume expansion 
induced increase in mean arterial pressure ≥ 10%) and pressure 
non‑responders















Fig. 4 Receiver‑operating characteristic curves showing the ability 
of baseline dynamic arterial elastance (Eadyn) and baseline mean 
arterial pressure (MAP) to predict an increase in MAP ≥ 10% following 
volume expansion
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norepinephrine, whereas it improves after volume 
expansion in patients free of norepinephrine. Such 
alterations may explain in part our results. Our find-
ings suggest that Eadyn was not helpful to predict an 
increase in arterial pressure after volume expansion in 
mechanically ventilated, preload-responsive and vaso-
pressor-free patients in the operating room.
Limitations
Our study presents several limitations: First, we did not 
randomize the order of volume expansion and neosyn-
ephrine infusion (all patients received volume expan-
sion before vasopressor infusion) and we only recorded 
the first volume expansion and the first vasopressor 
infusion done in each patient. Second, according to 
local practices, we chose neosynephrine and not nor-
epinephrine despite recent data suggesting the possi-
ble superiority of norepinephrine over neosynephrine 
in patients under general anesthesia in the operating 
room [30–32]. Third, the two linear mixed models show 
very different effects of hemodynamic covariates on the 
time course of Eadyn, PPV and SVV. In the two models, 
effects remained very low due to a foreseeable lack of 
power related to a low sample size.
Conclusion
To conclude, in this bicentre and prospective study, 
we observed that (i) neosynephrine infusion induced a 
decrease in Eadyn in a very large proportion of patients, 
whereas volume expansion induced a decrease in Eadyn 
in only two-thirds of patients, and (ii) Eadyn was poorly 
able to predict any increase in mean arterial pressure 
following volume expansion or neosynephrine infusion. 
Eadyn seems to be a sensitive marker of arterial tone 
changes following vasopressor infusion.
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